Huda Salman
Clinical trials sponsored by Huda Salman, explained in plain language.
-
Engineered immune cells aim to clear resistant leukemia before transplant
Disease control Recruiting nowThis early-phase trial tests a new therapy using a patient's own immune cells, engineered to target and kill leukemia cells that carry a protein called CD4. The goal is to safely reduce or eliminate remaining cancer in people with AML that has not responded to standard treatments…
Phase: PHASE1 • Sponsor: Huda Salman • Aim: Disease control
Last updated May 17, 2026 09:19 UTC
-
Engineered T-Cells take aim at Hard-to-Treat blood cancers
Disease control Recruiting nowThis early-phase study tests a new treatment called CD4CAR for people with T-cell leukemia or lymphoma that has come back or not responded to standard therapy. The treatment uses a patient's own immune cells, modified in a lab to target and attack cancer cells. The main goal is t…
Phase: PHASE1 • Sponsor: Huda Salman • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Engineered immune cells take aim at Hard-to-Treat leukemia
Disease control Recruiting nowThis early-stage trial tests a new treatment for chronic myelomonocytic leukemia (CMML) that has returned or not responded to standard therapy. The treatment uses a patient's own immune cells, modified to target and attack cancer cells. The main goals are to find a safe dose and …
Phase: PHASE1 • Sponsor: Huda Salman • Aim: Disease control
Last updated May 05, 2026 11:53 UTC